<DOC>
	<DOCNO>NCT00003396</DOCNO>
	<brief_summary>RATIONALE : Peripheral stem cell transplantation may able replace immune cell destroy chemotherapy radiation therapy use kill tumor cell . PURPOSE : Phase II trial study effectiveness peripheral stem cell transplantation relate donor prevent graft-versus-host disease treat patient hematologic cancer .</brief_summary>
	<brief_title>Peripheral Stem Cell Transplantation Treating Patients With Hematologic Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate use donor peripheral blood stem cell without graft-versus-host disease prophylaxis maximize probability graft-versus-tumor effect patient hematologic malignancy refractory standard chemotherapy unlikely cure high dose chemotherapy radiotherapy . OUTLINE : Prior peripheral blood stem cell transplant , patient undergo preparative cytoreduction . Patients receive total body irradiation ( TBI ) begin day -5 . Radiotherapy administer 9 dos 3 day ( 3 dos per day 3 day ) . Male patient acute lymphocytic leukemia receive additional dose radiation testicle . Patients ineligible TBI due prior radiotherapy receive 2 dos melphalan IV day -3 . All patient receive cyclophosphamide IV 1 hour day -2 -1 . Anti-thymocyte globulin also administer IV 6 hour day -2 -1 . Approximately 24-36 hour last dose cyclophosphamide , peripheral blood stem cell obtain HLA match related donor infuse patient . Patients receive graft-versus-host disease prophylaxis transplant ; however , form supportive care provide . Patients follow 1 year . PROJECTED ACCRUAL : A maximum 42 patient accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Plasmacytoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients HLA identical family donor one follow condition document marrow aspiration biopsy : Acute leukemia refractory induction treatment 1 relapse Acute myeloid leukemia ( 9 ; 22 ) , 5/5q , 7/7q , 11q23 involvement first remission ( M4 M5 ) Acute lymphocytic leukemia ( 9 ; 22 ) ( 4 ; 11 ) first remission Myelodysplastic syndrome great 5 % bone marrow blast Chronic myeloid leukemia accelerate phase nonlymphoid blast crisis Myeloma , chronic lymphocytic leukemia , nonHodgkin 's lymphoma , Hodgkin 's disease refractory 2 line standard treatment progression standard treatment No evidence active extramedullary disease PATIENT CHARACTERISTICS : Age : Any age Performance status : Karnofsky 70100 % Life expectancy : Greater 8 week Hematopoietic : Not specify Hepatic : Bilirubin le 2.0 mg/dL SGOT great 4 time upper limit normal increase 24 week prior transplant Renal : Creatinine le 2 time normal increase 24 week prior transplant OR Creatinine clearance great 60 mL/min Cardiovascular : LVEF great 50 % MUGA Pulmonary : DLCO great 50 % Other : Not HIV positive Not pregnant nursing Fertile patient must use effective contraceptive PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
	<keyword>refractory multiple myeloma</keyword>
	<keyword>Waldenstrom macroglobulinemia</keyword>
	<keyword>stage I multiple myeloma</keyword>
	<keyword>stage II multiple myeloma</keyword>
	<keyword>stage III multiple myeloma</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>relapse chronic myelogenous leukemia</keyword>
	<keyword>refractory chronic lymphocytic leukemia</keyword>
	<keyword>accelerated phase chronic myelogenous leukemia</keyword>
	<keyword>blastic phase chronic myelogenous leukemia</keyword>
	<keyword>adult acute myeloid leukemia remission</keyword>
	<keyword>adult acute lymphoblastic leukemia remission</keyword>
	<keyword>childhood acute myeloid leukemia remission</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>adult acute erythroid leukemia ( M6 )</keyword>
	<keyword>adult acute myeloblastic leukemia without maturation ( M1 )</keyword>
	<keyword>adult acute myeloblastic leukemia maturation ( M2 )</keyword>
	<keyword>adult acute promyelocytic leukemia ( M3 )</keyword>
	<keyword>adult acute eosinophilic leukemia</keyword>
	<keyword>adult acute basophilic leukemia</keyword>
	<keyword>adult acute megakaryoblastic leukemia ( M7 )</keyword>
	<keyword>childhood acute myeloblastic leukemia without maturation ( M1 )</keyword>
	<keyword>childhood acute myeloblastic leukemia maturation ( M2 )</keyword>
	<keyword>childhood acute promyelocytic leukemia ( M3 )</keyword>
	<keyword>childhood acute erythroleukemia ( M6 )</keyword>
	<keyword>childhood acute eosinophilic leukemia</keyword>
	<keyword>childhood acute basophilic leukemia</keyword>
	<keyword>childhood acute megakaryocytic leukemia ( M7 )</keyword>
	<keyword>recurrent/refractory childhood Hodgkin lymphoma</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>previously treat myelodysplastic syndrome</keyword>
	<keyword>adult acute minimally differentiate myeloid leukemia ( M0 )</keyword>
	<keyword>childhood acute minimally differentiate myeloid leukemia ( M0 )</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
	<keyword>childhood myelodysplastic syndrome</keyword>
</DOC>